{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:51:46Z","timestamp":1763621506567,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12308-023-00559-2","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T10:02:19Z","timestamp":1693389739000},"page":"191-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of IgG4-positive plasma cell population in classic Hodgkin lymphoma"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4948-0557","authenticated-orcid":false,"given":"Beril","family":"Guler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-2338","authenticated-orcid":false,"given":"Busra Cosanay","family":"Tekden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4265-8105","authenticated-orcid":false,"given":"Guven","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7709-7264","authenticated-orcid":false,"given":"Pelin","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-0369","authenticated-orcid":false,"given":"Seval","family":"Turna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8833-697X","authenticated-orcid":false,"given":"Omer","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3022-3147","authenticated-orcid":false,"given":"Irmak","family":"Sinal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"key":"559_CR1","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3390\/ijms20102416","volume":"20","author":"D Aldinucci","year":"2019","unstructured":"Aldinucci D, Borghese C, Casagrande N (2019) Formation of the immunosuppressive microenvironment of classic Hodgkin lymphoma and therapeutic approaches to counter it. Int J Mol Sci 20:2416. https:\/\/doi.org\/10.3390\/ijms20102416","journal-title":"Int J Mol Sci"},{"key":"559_CR2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","volume":"35","author":"MA Weniger","year":"2021","unstructured":"Weniger MA, K\u00fcppers R (2021) Molecular biology of Hodgkin lymphoma. Leukemia 35:968\u2013981. https:\/\/doi.org\/10.1038\/s41375-021-01204-6","journal-title":"Leukemia"},{"key":"559_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/bjh.15614","volume":"184","author":"HW Wang","year":"2019","unstructured":"Wang HW, Balakrishna JP, Pittaluga S, Jaffe ES (2019) Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol 184:45\u201359. https:\/\/doi.org\/10.1111\/bjh.15614","journal-title":"Br J Haematol"},{"key":"559_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","volume":"132","author":"FZ Cader","year":"2018","unstructured":"Cader FZ, Schackmann RC, Hu X, Wienand K, Redd R, Chapuy B et al (2018) Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell\u2013rich and exhausted T-effector microenvironment. Blood 132:825\u2013836. https:\/\/doi.org\/10.1182\/blood-2018-04-843714","journal-title":"Blood"},{"key":"559_CR5","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1182\/blood-2013-06-508044","volume":"122","author":"P Greaves","year":"2013","unstructured":"Greaves P, Clear A, Owen A, Iqbal S, Lee A, Matthews J et al (2013) Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood 122:2856\u20132863. https:\/\/doi.org\/10.1182\/blood-2013-06-508044","journal-title":"Blood"},{"key":"559_CR6","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1182\/blood.2019002206","volume":"134","author":"SS Patel","year":"2019","unstructured":"Patel SS, Weirather JL, Lipschitz M, Lako A, Chen P-H, Griffin GK et al (2019) The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4\u2013positive T cells that are PD-1\u2013negative. Blood 134:2059\u20132069. https:\/\/doi.org\/10.1182\/blood.2019002206","journal-title":"Blood"},{"key":"559_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/bjh.15703","volume":"184","author":"AR Gholiha","year":"2019","unstructured":"Gholiha AR, Hollander P, Hedstrom G, Sundstrom C, Molin D, Smedby KE et al (2019) High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms. Br J Haematol 184:192\u2013201. https:\/\/doi.org\/10.1111\/bjh.15703","journal-title":"Br J Haematol"},{"key":"559_CR8","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/1756-185X.13093","volume":"20","author":"SS Ahn","year":"2017","unstructured":"Ahn SS, Song JJ, Park YB, Lee SW (2017) Malignancies in Korean patients with immunoglobulin G4-related disease. Int J Rheum Dis 20:1028\u20131035. https:\/\/doi.org\/10.1111\/1756-185X.13093","journal-title":"Int J Rheum Dis"},{"key":"559_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00428-018-2460-8","volume":"473","author":"K Kiil","year":"2018","unstructured":"Kiil K, Bein J, Schuhmacher B, Thurner L, Schneider M, Hansmann M-L et al (2018) A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma. Virchows Arch 473:759\u2013764. https:\/\/doi.org\/10.1007\/s00428-018-2460-8","journal-title":"Virchows Arch"},{"key":"559_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1172\/JCI65579","volume":"123","author":"P Karagiannis","year":"2013","unstructured":"Karagiannis P, Gilbert AE, Josephs DH, Ali N, Dodev T, Saul L et al (2013) IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest 123:1457\u20131474. https:\/\/doi.org\/10.1172\/JCI65579","journal-title":"J Clin Invest"},{"key":"559_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K et al (2012) Risk of malignancies in IgG4-related disease. Mod Rheumatol 22:414\u2013418. https:\/\/doi.org\/10.1007\/s10165-011-0520-x","journal-title":"Mod Rheumatol"},{"key":"559_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/IOP.0000000000000965","volume":"34","author":"EJ Sohn","year":"2018","unstructured":"Sohn EJ, Ahn HB, Roh MS, Jung WJ, Ryu WY, Kwon YH (2018) Immunoglobulin G4 (IgG4)-positive ocular adnexal mucosa-associated lymphoid tissue lymphoma and idiopathic orbital inflammation. Ophthalmic Plast Reconstr Surg 34:313\u2013319. https:\/\/doi.org\/10.1097\/IOP.0000000000000965","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"559_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00428-017-2286-9","volume":"472","author":"JR Bledsoe","year":"2018","unstructured":"Bledsoe JR, Wallace ZS, Stone JH, Deshpande V, Ferry JA (2018) Lymphomas in IgG4-related disease: clinicopathologic features in a Western population. Virchows Arch 472:839\u2013852. https:\/\/doi.org\/10.1007\/s00428-017-2286-9","journal-title":"Virchows Arch"},{"key":"559_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.mpdhp.2013.01.005","volume":"19","author":"JA Ferry","year":"2013","unstructured":"Ferry JA (2013) IgG4-related lymphadenopathy and IgG4-related lymphoma: moving targets. Diagn Histopathol 19:128\u2013139. https:\/\/doi.org\/10.1016\/j.mpdhp.2013.01.005","journal-title":"Diagn Histopathol"},{"key":"559_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/MPA.0b013e31819d73ca","volume":"38","author":"N Takahashi","year":"2009","unstructured":"Takahashi N, Ghazale AH, Smyrk TC, Mandrekar JN, Chari ST (2009) Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 38:523\u2013526. https:\/\/doi.org\/10.1097\/MPA.0b013e31819d73ca","journal-title":"Pancreas"},{"key":"559_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/his.13965","volume":"76","author":"V Nowak","year":"2020","unstructured":"Nowak V, Agaimy A, Kristiansen G, G\u00fctgemann I (2020) Increased IgG4-positive plasma cells in nodular-sclerosing Hodgkin lymphoma: a diagnostic pitfall. Histopathology 76:244\u2013250. https:\/\/doi.org\/10.1111\/his.13965","journal-title":"Histopathology"},{"key":"559_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181\u201392. https:\/\/doi.org\/10.1038\/modpathol.2012.72","journal-title":"Mod Pathol"},{"key":"559_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/joim.12582","volume":"281","author":"I Glimelius","year":"2017","unstructured":"Glimelius I, Diepstra A (2017) Novel treatment concepts in Hodgkin lymphoma. J Intern Med 281:247\u2013260. https:\/\/doi.org\/10.1111\/joim.12582","journal-title":"J Intern Med"},{"key":"559_CR19","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","volume":"398","author":"P Brice","year":"2021","unstructured":"Brice P, de Kerviler E, Friedberg JW (2021) Classical Hodgkin lymphoma. Lancet 398:1518\u20131527. https:\/\/doi.org\/10.1016\/S0140-6736(20)32207-8","journal-title":"Lancet"},{"key":"559_CR20","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.3390\/ijms22084083","volume":"22","author":"A Nishikori","year":"2021","unstructured":"Nishikori A, Nishimura Y, Shibata R, Ohshima K-i, Gion Y, Ikeda T et al (2021) Upregulated expression of activation-induced cytidine deaminase in ocular adnexal marginal zone lymphoma with IgG4-positive cells. Int J Mol Sci. 22:4083. https:\/\/doi.org\/10.3390\/ijms22084083","journal-title":"Int J Mol Sci."},{"key":"559_CR21","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1097\/PAS.0b013e3181f12c85","volume":"34","author":"W Cheuk","year":"2010","unstructured":"Cheuk W, Tam FK, Chan AN, Luk IS, Yuen AP, Chan W-K et al (2010) Idiopathic cervical fibrosis\u2014a new member of IgG4-related sclerosing diseases: report of 4 cases, 1 complicated by composite lymphoma. Am J Surg Pathol 34:1678\u20131685. https:\/\/doi.org\/10.1097\/PAS.0b013e3181f12c85","journal-title":"Am J Surg Pathol"},{"key":"559_CR22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3324\/haematol.2015.132761","volume":"101","author":"S Vardhana","year":"2016","unstructured":"Vardhana S, Younes A (2016) The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints. Haematologica 101:794. https:\/\/doi.org\/10.3324\/haematol.2015.132761","journal-title":"Haematologica"},{"key":"559_CR23","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.3390\/ijms21145017","volume":"21","author":"R Bianchini","year":"2020","unstructured":"Bianchini R, Karagiannis SN, Jordakieva G, Jensen-Jarolim E (2020) The role of IgG4 in the fine tuning of tolerance in IgE-mediated allergy and cancer. Int J Mol Sci 21:5017. https:\/\/doi.org\/10.3390\/ijms21145017","journal-title":"Int J Mol Sci"},{"key":"559_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1440-1827.2010.02524.x","volume":"60","author":"Y Sato","year":"2010","unstructured":"Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T (2010) IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 60:247\u2013258. https:\/\/doi.org\/10.1111\/j.1440-1827.2010.02524.x","journal-title":"Pathol Int"},{"key":"559_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","volume":"32","author":"W Cheuk","year":"2008","unstructured":"Cheuk W, Yuen HK, Chan AC, Shih L-Y, Kuo T-T, Ma M-W et al (2008) Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol 32:1159\u20131167. https:\/\/doi.org\/10.1097\/PAS.0b013e31816148ad","journal-title":"Am J Surg Pathol"},{"key":"559_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12185-013-1359-z","volume":"98","author":"T Mitsui","year":"2013","unstructured":"Mitsui T, Yokohama A, Koiso H, Ishizaki T, Uchiumi H, Saitoh T et al (2013) Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma. Int J Hematol 98:122\u2013128. https:\/\/doi.org\/10.1007\/s12185-013-1359-z","journal-title":"Int J Hematol"},{"key":"559_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3960\/jslrt.51.125","volume":"51","author":"T Matsuo","year":"2011","unstructured":"Matsuo T, Ichimura K, Yoshino T (2011) Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. J Clin Exp Hematop 51:125\u2013133. https:\/\/doi.org\/10.3960\/jslrt.51.125","journal-title":"J Clin Exp Hematop"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-023-00559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-023-00559-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-023-00559-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:02:29Z","timestamp":1724976149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-023-00559-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s12308-023-00559-2","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"type":"print","value":"1868-9256"},{"type":"electronic","value":"1865-5785"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study has obtained IRB approval from by the ethics committee of our university (E-54022451\u2013050.05.04\u201396966) and the need for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of study, consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}